Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Boynton Beach, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Clearwater, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
DeLand, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
DeLand, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Fort Lauderdale, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Fort Lauderdale, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Hialeah, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Jupiter, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Jupiter, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Lakeland, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Lakeland, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Lynn Haven, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Lynn Haven, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Miami, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Miami, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Miami, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Miami, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Miami, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Orlando, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Orlando, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Port Orange, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tampa, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tampa, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tampa, FL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tampa, FL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Athens, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Athens, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Augusta, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Augusta, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Decatur, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Decatur, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Decatur, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Decatur, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Johns Creek, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Johns Creek, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Savannah, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Savannah, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Smyrna, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Smyrna, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Clive, IA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Clive, IA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Newton, KA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Newton, KA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Wichita, KA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Wichita, KA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Wichita, KA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Wichita, KA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Lexington, KY
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Lexington, KY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Lexington, KY
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Lexington, KY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Bastrop, LA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Bastrop, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Marrero, LA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Marrero, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Metairie, LA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Metairie, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
New Orleans, LA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
New Orleans, LA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Shreveport, LA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Chevy Chase, MD
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Boston, MA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Boston, MA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
New Bedford, MA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
New Bedford, MA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Chesterfield, MI
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Chesterfield, MI
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Flint, MI
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Flint, MI
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Rochester, MI
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Rochester, MI
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Saginaw, MI
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Saginaw, MI
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Southfield, MI
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Southfield, MI
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Biloxi, MS
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Biloxi, MS
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Jackson, MS
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Jackson, MS
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Omaha, NE
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Omaha, NE
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Henderson, NV
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Henderson, NV
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Las Vegas, NV
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials